Protalix BioTherapeutics, Inc. (PLX)
NYSEAMERICAN: PLX · IEX Real-Time Price · USD
1.120
-0.050 (-4.27%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Protalix BioTherapeutics Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for PLX stock has a target of 10, which predicts an increase of 792.86% from the current stock price of 1.12.
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 14, 2023.
Analyst Ratings
According to 1 stock analyst, the rating for PLX is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +792.86% | Nov 14, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $7 → $10 | Strong Buy | Maintains | $7 → $10 | +792.86% | Oct 31, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains n/a | Strong Buy | Maintains | n/a | n/a | May 3, 2021 |
| Rodman & Renshaw | Rodman & Renshaw | Strong Buy Reiterates n/a | Strong Buy | Reiterates | n/a | n/a | Apr 17, 2017 |
Financial Forecast
Revenue This Year
53.24M
from 65.49M
Decreased by -18.71%
Revenue Next Year
102.45M
from 53.24M
Increased by 92.43%
EPS This Year
0.12
from 0.09
Increased by 34.67%
EPS Next Year
0.64
from 0.12
Increased by 425.00%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 55.3M | 106.5M | 175.6M |
| Avg | 53.2M | 102.5M | 168.9M |
| Low | 51.7M | 99.4M | 163.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -15.5% | 100.1% | 71.4% |
| Avg | -18.7% | 92.4% | 64.9% |
| Low | -21.1% | 86.7% | 60.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 0.13 | 0.66 | 1.19 |
| Avg | 0.12 | 0.64 | 1.14 |
| Low | 0.12 | 0.62 | 1.11 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 40.0% | 445.8% | 86.5% |
| Avg | 34.7% | 425.0% | 79.4% |
| Low | 30.7% | 409.4% | 74.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.